On June 29, 2023, STEMCELL Technologies' Dr. Andrew Gaffney and Dr. Erin Knock presented on how to streamline PSC-related workflows using highly characterized induced pluripotent stem cells (iPSCs) and neural progenitor cells (NPCs), and how to differentiate these cells into a variety of cell types downstream. In this Q&A report, you can read their answers to questions asked by the audience. Answers have been edited for length and/or clarity.
In this webinar, Dr. Cameron Metcalf covers the technical requirements and benefits of spontaneous seizure models, addressing the challenges and optimization of 24/7 video-EEG data collection for epilepsy therapy development.
Semaglutide, also known as Ozempic and Wegovy, has become increasingly popular -- but why? Here we discuss the mechanism behind these drugs, how they've become so well known, and what current research says about their long-term effects.
A recent publication from Singh et al. demonstrate how taurine, an amino acid used widely throughout the body, can improve age-related health outcomes in mice, roundworms, non-human primates, and also highlight how this effect appears to be evolutionarily conserved in humans.
Neurophysiology: Exploring Basic Research and Clinical Consequences - A webinar series covering fundamentals, late-breaking research, and novel discoveries in the field of neuroscience & related disease models.
What can biological age tell us about our health? Is it a fixed number, or can it be reduced? A recent study from Poganik et al. investigates the fluctuations in biological age in response to physiological stress.
Clarisa Peer discusses ALZET Osmotic Pumps, the gold standard for controlled, automatic dosing of compounds in various research areas, including neuroscience, cancer research, cardiovascular, endocrinology, pharmacology research, and more.
Chemotherapy treatment is incredibly difficult on patient wellbeing, but an unlikely plant-derived substance may yet improve the adverse side effects. In this blog, we discuss the use of CBD as a treatment for side effects like organ damage and drug resistance in cancer patients receiving chemotherapy.
Nataliia Beztsinna and Marten Hornsveld describe how the tumor microenvironment modulates clinical responses and how patient-derived ex vivo and engineered in vitro models can be used for pre-clinical immuno-oncology testing.
While the immune response to a single cardiac event has been well researched, few have reported on whether an adaptive immunity is observed after repeated cardiac injury. Here, we discuss a recent publication from Tiwary et al., in which they investigate the cytoprotective response after multiple cardiomyopathic injuries.